DiogenX

Biotechnology ResearchHauts-de-france, France11-50 Employees

DiogenX is a preclinical-stage biotechnology company focused on developing innovative biologics as potential therapies for diabetes, with a lead program that aims to restore beta-cell function to rebalance glucose and insulin homeostasis. Its work centers on regenerating insulin-producing beta cells, offering a distinct approach to treating diabetes and addressing the needs of patients who require new therapeutic options. Headquartered in Marseille, France, the company operates laboratories in Nice and positions itself within the biotechnology research sector as a developer of first-in-class regenerative strategies. The organization has a growing profile in the field, supported by leadership additions and board appointments in recent years that reflect its ongoing development trajectory. DiogenX is based in the Hauts-de-France region, and its activities are anchored in the preclinical research space as it advances its lead program toward potential clinical evaluation.

Sign up for free to view info

Email Format Employee directory